Growth Metrics

Compass Therapeutics (CMPX) Notes Payables (2018 - 2020)

Compass Therapeutics recorded quarterly Notes Payables of $103110.0 in Q1 2020, up 10.74% quarter-over-quarter from $93110.0 in Q4 2019, and up 42.96% year-over-year from $72125.0 in Q2 2019.

Compass Therapeutics' Notes Payables history runs 3 years deep, the most recent figure standing at $103110.0 for Q1 2020.

  • In Q1 2020, Notes Payables rose 42.96% year-over-year to $103110.0; the TTM figure through Mar 2020 stood at $103110.0 (up 42.96% YoY), while the FY2020 annual figure was $103110.0, up 42.96% from the prior year.
  • Notes Payables came in at $103110.0 for Q1 2020 at Compass Therapeutics, up from $93110.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $103110.0 in Q1 2020 to a low of $34525.0 in Q1 2018.
  • A 3-year average of $69108.9 and a median of $72125.0 in 2019 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables surged 108.91% in 2019 and jumped 42.96% in 2020, its largest moves.
  • Compass Therapeutics' Notes Payables stood at $62125.0 in 2018, then soared by 49.88% to $93110.0 in 2019, then gained by 10.74% to $103110.0 in 2020.
  • According to Business Quant data, Notes Payables over the past three periods registered $103110.0, $93110.0, and $85610.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Compass Therapeutics 418.47 Mn 223.78 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 103,110.00
Dec 31, 2019 93,110.00
Sep 30, 2019 85,610.00
Jun 30, 2019 72,125.00
Mar 31, 2019 72,125.00
Dec 31, 2018 62,125.00
Sep 30, 2018 49,625.00
Jun 30, 2018 49,625.00
Mar 31, 2018 34,525.00